Product Pipeline

PTG-100: An oral GI-restricted α4β7 integrin-specific antagonist for the treatment of moderate-to-severe UC

PTG-200: A first-in-class oral GI-restricted IL-23R antagonist for the treatment of moderate-to-severe Crohn’s disease

PTG-300: An injectable hepcidin mimetic for potential treatment of iron overload related rare diseases